Nass Valley Gateway Limited -- Corporate Update
Nass Valley welcomes Mr. Elliott to the Board of Directors. With his experience in senior roles as Chief Executive and Technology Officer, Principal Engineer, Special Project Engineer and his expertise in CBD extraction, Medical Devices, Diagnostics and IVD sectors he will contribute in a very proactive way to the Company's success subsequent to the closing of its proposed transaction.
The Board of Directors appointed the following officers and committee members:
Officers
- President & CEO: Dieter Peter
- Interim Chief Financial Officer and Corporate Secretary: Eric Peter-Kaiser
- Audit Committee: Andrew von Kursell, James Elliott, and Milo Filgas;
- Advisory Committee: Members to be nominated during the ensuing year.
The Board decided not to establish any other board committees until it has received the final approval from the CSE for their proposed transaction for the acquisition of "Advanced Bioceuticals Limited" and "Pro-Thotics Technology Inc".
WE SEEK SAFE HARBOUR..
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
Trading Symbols
CSE: NVG
Deutsche Borse, Frankfurt: 3NVN
Germany: WKN A1JVHM / ISIN CA6315202029
SOURCE Nass Valley Gateway Ltd.
Contact
please contact: Dieter Peter, President & CEO
Phone: 604-617-6794
www.nassvalleygateway.com